PharmaCan Capital Corp. — Form D
PharmaCan Capital Corp. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-27. The offering totals $10.8M, of which $4.6M was reported sold. Industry: Investing.
Offering
- Filed: 2016-05-27
- Form: D
- Accession: 0001656472-16-000002
- Industry: Investing
- Exemptions: 06b
- Total offering: $10.8M
- Amount sold: $4.6M
- Remaining: $6.1M
- Investors: 21
- Date of first sale: 2016-05-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-264049
Issuer
- Name: PharmaCan Capital Corp.
- CIK: 0001656472
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2012
- Address: 76 STAFFORD STREET, SUITE 302, TORONTO, A6, M6J 2S1
- Phone: (416) 504-0004
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Alan Friedman | Director | TORONTO, A6 |
| Michael Gorenstein | Director | Toronto, A6 |
| Michael Howard Krestell | Director | Toronto, A6 |
| Michael Gorenstein | Executive Officer | Toronto, A6 |
| Glen Huber | Executive Officer | Toronto, A6 |
| Ryan Roebuck | Director | Vancouver, A1 |
| Paul Rosen | Director | TORONTO, A6 |
| Paul Rosen | Executive Officer | TORONTO, A6 |
| Lorne Gertner | Director | Chicago, IL |
| Glen Huber | Director | Toronto, A6 |
| Steven Howard Isenberg | Director | Toronto, A6 |
Other filings by this issuer (1)
More